Patent · US Active

Phosphatidylinositol 3-kinase inhibitors

US10214519B2 · kind B2 · utility

0Cited by
45References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 21, 2017
Grant dateFeb 26, 2019
Priority date—
Expiry dateSep 21, 2037

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2300/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present application provides the compounds of formula I or IA

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.